APUS
Apimeds Pharmaceuticals US, Inc.
stockNYSEAMERICAN
At CloseOct 22, 2026 3:57:12 PM EDT
3.11USD-3.115%(-0.10)42,215
Pre-marketOct 22, 2026 8:57:30 AM EDT
3.20USD-0.312%(-0.01)
After-hoursOct 22, 2026 4:16:30 PM EDT
3.11USD0.000%(0.00)
APUS Financials
In Q2 FY 2026 (ended ), Apimeds Pharmaceuticals US, Inc. (APUS) reported net income of −$20.17M, operating cash flow of −$5.67M, and assets of $127.62M.
Loading financial statements…